Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
No-Receipt date
2021-01953 - 24/05/2021
No-Filing date
20210401352 - 24/05/2021
No-Granting date
3107267 - 28/05/2021
No-EPO application date
14855002.3 - 17/10/2014
No-EPO granting date
3060908 - 24/02/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2021 - 14/06/2021
Expiration date
18/10/2034
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201361893542 P21/10/2013/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/00
G01N 33/00
G01N 33/564
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1385059
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU,
OSAKA-SHI, OSAKA 541-0045, JAPAN
JAPAN
Inventors
Code
Firstname
Surname
3310046
SEXTON, DANIEL, J.
3310047
ADELMAN, BURT
3310048
NIXON, ANDREW
Representatives
Code
Firstname
Surname
Address
Town
Zip
3614
AIKATERINI
SIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
26/10/2021
Μεταβίβαση (7e802)
Α.Π.13151, ΑΡ.ΥΠ.4391796, ΔΝΥ.1721, ΚΩΔ.ΠΛΗΡ.3458
1293521 Dyax Corp. 300 Shire Way ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lexington, MA 02421
1385059 Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome, Chuo-ku, ΙΑΠΩΝΙΑ Osaka-shi, Osaka 541-0045, JAPAN
Title Instruments
Payments history
11 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).